JPRN-jRCT2031220067招募中未知
Post-marketing surveillance of AMYViD Injection
Kazunori Bando0 个研究点目标入组 500 人开始时间: 2022年5月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who received AMYViD Injection during the enrollment period of this study.
排除标准
- •Patients who enrolled in other clinical studies or clinical trials during the enrollment period of this study.
研究者
相似试验
已完成
Unknown
Post-Marketing Surveillance of Acofide in Patients with Functional DyspepsiaFunctional DyspepsiaJPRN-jRCT1080222794ZERIA Pharmaceutical Co.,Ltd.3,000
未知
Unknown
Post-marketing surveillance of administration of botulinum toxin type B(NerBloc)-investigation of the clinical condition in patients with changing from botulinum toxin type Acervical dystoniaJPRN-jRCT1080222128Eisai Co., Ltd.150
已完成
Unknown
Post-marketing surveillance of administration of botulinum toxin type B(NerBloc)-Investigation of the clinical condition and safety in patients with cervical dystoniacervical dystoniaJPRN-jRCT1080222127Eisai Co., Ltd.
招募中
Unknown
All case study of Lenvima Capsulenresectable thyroid cancerJPRN-jRCT1080222856Eisai Co., Ltd.400
已完成
不适用
Post-marketing surveillance of Vadadustat in patients with anemia in chronic kidney disease for long-term efficacy and safetyRenal anemiaJPRN-UMIN000042349Mitsubishi Tanabe Pharma Corporation2,000